Hu Galen Y, Prasad Jaideep, Chen Dinah K, Alcantara-Castillo Jennifer C, Patel Vipul N, Al-Aswad Lama A
Grossman School of Medicine, New York University, New York, New York; Department of Population Health, New York University Langone Health, New York, New York.
Grossman School of Medicine, New York University, New York, New York; Department of Ophthalmology, New York University Langone Health, New York, New York.
Ophthalmol Glaucoma. 2023 Mar-Apr;6(2):121-128. doi: 10.1016/j.ogla.2022.05.001. Epub 2022 May 14.
Our aim was to assess the acceptability and feasibility of iCare HOME tonometer (HT) and Virtual Field (VF) devices in the home monitoring of glaucoma.
Prospective feasibility and acceptability study.
Twenty patients (39 eyes) with primary open-angle glaucoma, open-angle glaucoma, ocular hypertension, or suspected glaucoma.
Patients were trained and instructed to bring 2 devices home for 1 week and use the HT 4 times/day for 4 days and the VF 3 times total.
For acceptability, we conducted satisfaction surveys and semistructured, qualitative interviews with a thematic analysis. Feasibility was assessed by device usage and quality of tests.
Most patients (73.7%) felt that the HT was easy to use, and 100% of them found the HT useful. All patients (100%) felt that VF was easy to use, and 94.4% of them found the VF useful. All patients (100%) obtained acceptable intraocular pressure and completed a VF test at home. We identified 4 key themes, with 33 subthemes. The key themes include the following: (1) advantages of home monitoring; (2) difficulties with home monitoring; (3) future considerations in home monitoring; and (4) the experience of patients with glaucoma.
The HT and VF were acceptable and feasible in a small cohort of motivated subjects. Patients were able to perform these tests proficiently at home, and they were generally enthused to obtain more data about their intraocular health, as it allowed them a heightened sense of security and insight about their chronic disease, as well as a reduction in foreseeable barriers to care. Home monitoring may also improve upon glaucoma care by enhancing patient empowerment and fostering community bonds. The VF should be further evaluated to ensure validity.
FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
我们的目的是评估iCare HOME眼压计（HT）和虚拟视野（VF）设备用于青光眼家庭监测的可接受性和可行性。
前瞻性可行性和可接受性研究。
20例患有原发性开角型青光眼、开角型青光眼、高眼压症或疑似青光眼的患者（39只眼）。
对患者进行培训并指导其将2种设备带回家使用1周，使用HT每天4次，共4天，VF总共使用3次。
对于可接受性，我们通过满意度调查以及采用主题分析的半结构化定性访谈来进行评估。通过设备使用情况和测试质量评估可行性。
大多数患者（73.7%）认为HT易于使用，其中100%的患者认为HT有用。所有患者（100%）都觉得VF易于使用，94.4%的患者认为VF有用。所有患者（100%）在家中获得了可接受的眼压测量值并完成了VF测试。我们确定了4个关键主题，包含33个子主题。关键主题如下：（1）家庭监测的优势；（2）家庭监测的困难；（3）家庭监测的未来考量；（4）青光眼患者的体验。
在一小群有积极性的受试者中，HT和VF是可接受且可行的。患者能够在家中熟练地进行这些测试，并且他们普遍热衷于获取更多关于其眼内健康的数据，因为这让他们对自己的慢性病有更强的安全感和了解，同时减少了可预见的护理障碍。家庭监测还可能通过增强患者自主权和促进社区联系来改善青光眼护理。VF应进一步评估以确保其有效性。
在参考文献之后可能会有专有或商业披露信息。
Zotero 插件